Hints and tips:
Related Special Reports
Related Topics
...It comes at a challenging time for the drugmaker, which is hoping to convince investors of its post-pandemic growth potential after $93bn of revenues from Covid vaccines and treatments during the pandemic...
...It was comforting to learn that some action is already being taken to remediate the vaccine inequity in low and middle income countries....
...“Potentially, this is much broader than Covid vaccines or vaccines in general.”...
...Valued at more than $40bn at the height of the pandemic in early 2021, Novavax made a series of mis-steps with the launch of its Covid vaccine....
...vaccine....
...Being able to deploy a vaccine mid-pandemic opened a new chapter in medical history....
...Last year, the government asked Novavax, another non-mRNA vaccine maker, to pay back $112mn shelled out for vaccines that it later did not want....
...university’s vaccine knowledge project....
...in the uptake of the measles vaccine Examine how the UK’s rate of measles infections compares to other European countries ‘Lower uptake of the measles vaccine is driven by issues of access not vaccine...
...A global system for sharing genomic and other data is considered crucial for surveillance against current and emerging pathogens and the development of drugs and vaccines to fight them....
...The World Health Organization has added Oxford university’s malaria vaccine to its list of pre-qualified vaccines, a vital step in paving the way for large-scale procurement by international bodies such...
...Peter Welford, an analyst at Jefferies, said “long-acting HIV injectables, vaccines and new pipeline launches mean profits likely face a ‘blip’ not ‘cliff’ on [HIV patent expirations]”....
...If it succeeds in a phase 3 trial, the vaccine would compete with approved RSV shots from GSK and Pfizer, and potentially one from Moderna....
...Regulators have not yet approved the vaccine for senior citizens. Trindade said Brazil was the first country to incorporate a dengue vaccine into its free public health system....
...“Factors determining demand for and acceptance of vaccines in countries are multifactorial, context-specific and vary across vaccines and time,” Kluge said....
...Our Ghana trial explored the effect of the scheme on individuals who did not receive cash for vaccines....
...“Rather than having a flu booster every year, if you have a Baseimmune vaccine, you maybe have a vaccine once every five years....
...Their rejection has deepened the sense that the recovered heroin addict and avowed vaccine sceptic is zany and self-promoting....
...Interestingly, the CDC has now shared the candidate vaccine virus 2.3.4.4b with manufacturers....
...GSK has upgraded its full-year guidance after a strong quarter in which sales of vaccines, including the world’s first jab for the respiratory syncytial virus, helped the drugmaker beat expectations....
...Transport secretary Mark Harper told broadcasters that a “very high base” from the 2021 race — the last time these seats were up for election — when the party benefited from a boost from the rollout of Covid vaccines...
...The suit filed in Delaware district court on Thursday is the latest in a string of actions taken against Pfizer and BioNTech over their Comirnaty vaccine....
...The World Health Organization regularly updates a list of known candidate vaccine viruses (CVVs) to respond to bird flu and other potential pandemic risks....
...Total sales for the quarter were £7.4bn, ahead of a company-compiled consensus, and driven by slightly higher than expected income from the company’s shingles vaccine and HIV treatments....
...Pfizer swung to a loss in the third quarter after a $5.6bn inventory write-off related to its Covid-19 antiviral and vaccine....
International Edition